Year-over-year earnings per share growth for the last twelve months: Xencor, Inc. (XNCR)

xencor.com (XNCR) - corporate logo

Diversification through technology licensing to global pharma behemoths stabilizes revenues for Xencor, Inc. (XNCR), as confirmed by the quarterly earnings per share change presented on GURU.Markets; the 723.40 mark reflects the latest data. Specialized antibody logistics guarantee therapy efficacy. The company is currently scaling its biospecific drug platform, advancing clinical trials for next-generation medications.

Xencor Inc (XNCR) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for xencor.com (XNCR)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Xencor Inc, XNCR
Manufactured product of Xencor, Inc.

For Xencor, Inc. (XNCR), the quarterly EPS growth profile on GURU.Markets reflects the dynamics of net profit per share. This metric measures the percentage change in earnings relative to the same period last year. Growth in this indicator confirms the effectiveness of R&D monetization through licensing payments from pharma partners. The positive trend signals the company's ability to cover capital expenditures, allowing investors to assess the fundamental stability of the biotechnology business.

Competitors of Xencor, Inc.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|CMPX - Year-over-year earnings per share growth for the last twelve months|REPL (replimune.com) - Year-over-year earnings per share growth for the last 12 months|Lyell Pharma (LYEL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Innate Pharma, S.A. (IPHA)|Year-over-year net earnings per share growth for the last 12 months PYXS|CGEN - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months IOBT (IO Biotech Corp)|Year-over-year earnings per share growth rate for the last twelve months STRO|Quarterly EPS earnings growth INKT (MiNK Therapeutics)|Year-over-year earnings per one share growth for the last 12 months HOWL|Immix - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ALX Oncology Holdings Inc.|CUE: Quarterly EPS earnings growth|PDS Biotech - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIA Biotech|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP